ARK Genomic Revolution ETF vs Celestica Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.49, while Celestica Inc trades at $315.1 (market cap $39.16B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Celestica Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | CLS | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $472.40 |
52-Week Low | $24.02 | $181.34 |
Market Cap | — | $39.16B |
Enterprise Value | — | $39.44B |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Celestica provides supply chain and manufacturing solutions for global technology companies. It specializes in high-complexity assembly and platform solutions for AI data centers, aerospace, and medical markets.
Read more on CLS →